SealBiosciences Inc
www.sealbiosciences.comA new diagnostic biomarker for colorectal cancer Seal Biosciences is developing a new prognostic biomarker as a companion diagnostic (CDx) that can determine which patients should receive anti-EGF therapy in metastatic colorectal cancer.
Read more
A new diagnostic biomarker for colorectal cancer Seal Biosciences is developing a new prognostic biomarker as a companion diagnostic (CDx) that can determine which patients should receive anti-EGF therapy in metastatic colorectal cancer.
Read more
Country
State
California
City (Headquarters)
San Francisco
Industry
Employees
1-10
Founded
2015
Social
Employees statistics
View all employeesPotential Decision Makers
Executive Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(12)
Reach decision makers at SealBiosciences Inc
Free credits every month!
SealBiosciences Inc FAQ
San Francisco, United States
Biotechnology Research
